Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Jevtana: Global Drug Analysis 2017 with Sales Forecasts to 2026 - ResearchAndMarkets.com

Research and Markets
Posted on: 15 Feb 18

The "Drug Analysis: Jevtana" drug pipelines has been added to ResearchAndMarkets.com's offering.

Jevtana (cabazitaxel; Sanofi) is a microtubule inhibitor indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with a docetaxel-containing treatment regimen.

By promoting tubulin assembly into microtubules while simultaneously preventing disassembly, Jevtana inhibits mitotic and interphase cellular functions, non-specifically inhibiting cell replication.

Key Topics Covered:

Product Profiles

Jevtana: Prostate cancer

List of Figures

Figure 1: Jevtana for prostate cancer - SWOT analysis

Figure 2: Drug assessment summary of Jevtana for prostate cancer (1)

Figure 3: Drug assessment summary of Jevtana for prostate cancer (2)

Figure 4: Jevtana sales for prostate cancer across the US, Japan, and five major EU markets, by country, 2017-26

List of Tables

Table 1: Jevtana drug profile

Table 2: Jevtana pivotal Phase III data in prostate cancer

Table 3: Jevtana Phase III data in prostate cancer

Table 4: Jevtana sales for prostate cancer across the US, Japan, and five major EU markets, by country ($m), 2017-26

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/vxgw7r/jevtana_global?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180215005695/en/

Business Wire
www.businesswire.com

Last updated on: 15/02/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.